Tech Company Financing Transactions
Concinnity Funding Round
Eos Advisory, Maven Capital Partners and Old College Capital invested in a $3.8 million Seed funding round for Concinnity. The round was announced on 12/16/2024.
Transaction Overview
Company Name
Announced On
12/16/2024
Transaction Type
Venture Equity
Amount
$3,800,000
Round
Seed
Investors
Proceeds Purpose
This funding will enable Concinnity to spin out from the UKRI UK Centre for Mammalian Synthetic Biology at the University of Edinburgh.
Company Information
Company Status
Private & Independent
Industry
AdTech
Mailing Address
2.28 Michael Swann Building, Max Born Crescent
Edinburgh, EH9 3BF
UK
Edinburgh, EH9 3BF
UK
Phone
Undisclosed
Website
Email Address
Overview
Enabling the next generation of gene therapies; Safety of cell and gene therapies remains a major concern in the biopharmaceutical industry. Concinnity was formed out of the University of Edinburgh in 2023 to transform the safety of gene therapies by designing novel control mechanisms using its cutting-edge AI platform and synthetic biology expertise.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Jessica Birt
Chief Scientific Officer
Matthew Dale
Browse more venture capital transactions:
Prev: 12/16/2024: Chargezoom venture capital transaction
Next: 12/16/2024: CredibleX venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs